Anthropic Announces AI for Science Research Grants for Rare Diseases

Anthropic is launching a new initiative under its AI for Science program focused on rare genetic diseases. The program provides accepted applicants with up to $50,000 in Claude API credits over six months to support research and drug development. By creating a community of researchers, the initiative aims to foster collaboration and accelerate the discovery of disease mechanisms and therapeutic solutions for conditions that are often studied in isolation.

The program features two distinct tracks. The first track supports basic science research, encouraging partnerships between clinical researchers and data scientists to improve disease classification and diagnostic accuracy. The second track is designed for early-stage biotechs and researchers working to expedite clinical development. Participants in this track may use AI to streamline regulatory documentation, analyze therapeutic targets, and identify shared mechanisms across different diseases to potentially simplify the clinical trial process.

Rare diseases affect hundreds of millions of people globally, yet they remain difficult to study due to small patient populations and fragmented data. Anthropic intends for these grants to help researchers synthesize existing literature, extract information from limited datasets, and model complex genetic patterns. While the company acknowledges that AI cannot solve challenges related to data scarcity or healthcare access, it hopes this program will demonstrate how artificial intelligence can overcome specific bottlenecks in scientific discovery and drug development. Applications for the grants are open until August 2, 2026.